Correction to: Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer

被引：0
|
作者：
Michel L. Peters
Claudine de Meijer
Dirk Wyndaele
Walter Noordzij
Annemarie M. Leliveld-Kors
Joan van den Bosch
Pieter H. van den Berg
Agni Baka
Jennifer G. Gaultney
机构：
[1] Real World Strategy and Analytics,Department of Nuclear Medicine
[2] Mapi Group,Department of Nuclear Medicine and Molecular Imaging
[3] Bayer B.V.,Department of Urology
[4] Catharina Ziekenhuis,Department of Internal Medicine
[5] University of Groningen,Department of Internal Medicine
[6] University Medical Centre Groningen,undefined
[7] University of Groningen,undefined
[8] University Medical Centre Groningen,undefined
[9] Albert Schweitzer Ziekenhuis,undefined
[10] Tergooi Ziekenhuizen,undefined
[11] Real World Strategy and Analytics,undefined
[12] Mapi Group,undefined
来源：
Applied Health Economics and Health Policy | 2018年 / 16卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
The article Dutch Economic Value of Radium-223 in Metastatic Castration-Resistant Prostate Cancer, written by Michel L. Peters, Claudine de Meijer, Dirk Wyndaele, Walter Noordzij, Annemarie M. Leliveld-Kors, Joan van den Bosch, Pieter H. van den Berg, Agni Baka, Jennifer G. Gaultney was originally published electronically on the publisher’s internet portal (currently SpringerLink) on 2nd September, 2017 without open access.
引用
收藏
页码：145 / 145
相关论文
共 50 条
  • [31] Radium-223 in metastatic castration-resistant prostate cancer: current status and future perspectives
    Wyndaele D.N.J.
    [J]. Tijdschrift voor Urologie, 2020, 10 (6-7) : 131 - 140
  • [32] When to Initiate Treatment With Radium-223 in Patients With Metastatic Castration-Resistant Prostate Cancer
    Shore, Neal D.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2016, 14 (01) : 26 - 29
  • [33] RADIUM 223 FOR THE TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER
    Miranda, Jesus
    Vinal, David
    Pinto, Alvaro
    [J]. ARCHIVOS ESPANOLES DE UROLOGIA, 2019, 72 (05): : 500 - 507
  • [34] Combination Therapy With Radium-223 and Enzalutamide in Castration-Resistant Prostate Cancer
    Maughan, Benjamin L.
    [J]. CLINICAL ADVANCES IN HEMATOLOGY & ONCOLOGY, 2021, 19 (12) : 764 - 766
  • [35] Evolving treatment approaches for the management of metastatic castration-resistant prostate cancer - role of radium-223
    Mukherji, Deborah
    El Dika, Imane
    Temraz, Sally
    Haidar, Mohammed
    Shamseddine, Ali
    [J]. THERAPEUTICS AND CLINICAL RISK MANAGEMENT, 2014, 10 : 373 - 380
  • [36] High-Dose Testosterone and Radium-223 Response in Metastatic Castration-Resistant Prostate Cancer
    Christensen, Bryce Raymon
    Barata, Pedro C.
    Ledet, Elisa M.
    Layton, Jodi L.
    Lewis, Brian E.
    Sartor, Oliver
    [J]. CLINICAL GENITOURINARY CANCER, 2019, 17 (06) : 476 - 479
  • [37] Radium-223 Dichloride in Peritoneal Dialysate Following Treatment of Metastatic Castration-resistant Prostate Cancer
    Saganich, Christopher
    Zgaljardic, Michael
    [J]. HEALTH PHYSICS, 2022, 122 (03): : 433 - 439
  • [38] Radium-223 in patients with metastatic castration-resistant prostate cancer: Efficacy and safety in clinical practice
    Prelaj, Arsela
    Rebuzzi, Sara Elena
    Buzzacchino, Federica
    Pozzi, Chiara
    Ferrara, Carla
    Frantellizzi, Viviana
    Follacchio, Giulia Anna
    Civitelli, Liana
    De Vincentis, Giuseppe
    Tomao, Silverio
    Bianco, Vincenzo
    [J]. ONCOLOGY LETTERS, 2019, 17 (02) : 1467 - 1476
  • [39] Lymph Node Response in a Patient With Metastatic Castration-resistant Prostate Cancer Treated With Radium-223
    Poon, Darren M. C.
    Wong, Kenneth C. W.
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : E397 - E401
  • [40] DNA Repair Pathway Alterations in Metastatic Castration-resistant Prostate Cancer Responders to Radium-223
    Ramos, Jorge D.
    Mostaghel, Elahe A.
    Pritchard, Colin C.
    Yu, Evan Y.
    [J]. CLINICAL GENITOURINARY CANCER, 2018, 16 (02) : 106 - 110
12345